Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial.
Xiaofeng ChenXiang XuDanping WangJinyuan LiuJing SunMingjie LuRui WangBingqing HuiXiaofei LiChenchen ZhouMin WangTianzhu QiuShiyun CuiNana SunYang LiFufeng WangCuicui LiuYang ShaoJinhua LuoYan-Hong GuPublished in: Journal for immunotherapy of cancer (2023)
NCT03946969.